CTRI/2019/08/020552尚未招募2 期
Combination of Rifaximin and branch chain aminoacids in treatment of hepaticencephalopathy- a randomized controlled study
Pavan kumar KV0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)patient with hepatic encephalopathy diagnosed according to West Haven criteria.
- •2)All types of hepatic encephalopathy induced by autoimmune, viral, alcoholic, biliary etiology
排除标准
- •1] presence of a major neuropsychiatric illness,
- •2] hypersensitivity to RIFAXIMINand BCAA,
- •3]Presence of inflammatory bowel diseases and intestinal obstruction
- •4]Serum creatinine levels > twice normal
- •5]Pregnant and lactating mothers
研究者
相似试验
进行中（未招募）
1 期
Rifaximin in the prevention of alcoholic liver diseaseEUCTR2014-001856-51-DKAleksander Krag136
已完成
不适用
A study to compare effects of Tablet Rifaximin alone and in combination with Tablet Norfloxacin for prevention of re-occuring bacterial infection of abdominal fluid and brain function abnormality due to liver disease.CTRI/2021/09/036321Pt BD Sharma PGIMS Rohtak49
尚未招募
不适用
Hemodynamic Response of Rifaximin plus Non-selective ß-blocker versus non-selective ß-blocker monotherapy in Cirrhotic Patients with esophageal varicesDiseases of the digestive systemKCT0000788Yonsei University, Wonju Severance Christian Hospital140
招募中
3 期
Combination of rifaximin, plasma exchange, and stem cell based therapy for severe alcoholic hepatitisCTRI/2023/04/052118PGIMER, Chandigarh
进行中（未招募）
不适用
Effects of rifaximin administration in patients with severe acute alcoholic hepatitis. Comparative pilot study.EUCTR2012-000515-80-ESJuan Córdoba